DMIIU CEO Lynn Stockwell resigns after Sponsor fails to repay $566K overpayment; Roger Bendelac appointed CEO

Drugs Made In America Acquisition II Corp.

Lynn Stockwell resigned as CEO, Executive Chair, and Board member on Feb 28, 2026, after Board learned Sponsor could not repay $566,269 overpayment.
Board accepted resignation and removed Stockwell from all positions effective Feb 28, 2026.
Roger Bendelac, 69, with 30+ years in investment banking and advisory, appointed CEO effective Feb 28, 2026.
Sponsor withdrew $1.1M from working capital; $566K+ used for expenses unrelated to the Company and not repaid.
Bendelac's compensation not yet determined; Board will consider and disclose terms later.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.